Watch Ticker

Amgen Inc

Go to Amgen Inc Website

$298.54

1.66 (0.56%)

Live

Previous Close

$296.88

Day Range

$296.295 - $300

Previous Day Range

$292.59 - $298.52

Market Cap

$159.6 billion USD

Day Vol.

567467

Previous Day Vol.

2.4 million

Currency

USD

Primary Exchange

Nasdaq

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Stefon Walters - The Best High-Yield Dividend ETF to Own for the Next 10 Years

The Schwab U.S. Dividend Equity ETF offers investors a reliable, low-cost dividend investment option with a rigorous selection criteria and consistent yield of around 3%, making it attractive for long-term investors seeking stable returns.

Related tickers: SCHD, KO, ABBV, AMGN.

Read Full Article

Vandana Singh - AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

AstraZeneca reported positive Phase 3 trial results for gefurulimab, a drug candidate treating generalized myasthenia gravis, demonstrating significant improvement in patient symptoms with no new safety concerns.

Related tickers: AZN, JNJ, AMGN, RNAC.

Read Full Article

Trending Tickers

Please sign in to view